Reaction
Small Intestinal Stenosis reporting signals
As of the last recalculation, Small Intestinal Stenosis appears in 1,050 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB (PRR 26.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab | 511 | 26.9 | 27.0 |
| Azathioprine | 105 | 26.1 | 26.2 |
| Vedolizumab | 99 | 25.0 | 25.1 |
| Mesalamine | 59 | 22.0 | 22.0 |
| Cholestyramine | 13 | 21.6 | 21.6 |
| Infliximab-Dyyb | 27 | 18.8 | 18.8 |
| Mercaptopurine | 14 | 16.2 | 16.2 |
| Risankizumab-Rzaa | 63 | 16.2 | 16.2 |
| Teduglutide | 9 | 13.3 | 13.4 |
| Infliximab | 129 | 13.2 | 13.2 |
| Ustekinumab | 49 | 9.9 | 9.9 |